Cart
sales@molnova.com
Ddr1-In-1
CAS No. 1449685-96-4
Ddr1-In-1( —— )
Catalog No. M17304 CAS No. 1449685-96-4
DDR1-IN-1 is an effective and specific DDR1 receptor tyrosine kinase inhibitor (IC50: 105 nM), about 3-fold selectivity over DDR2.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 43 | In Stock |
|
| 5MG | 69 | In Stock |
|
| 10MG | 105 | In Stock |
|
| 25MG | 162 | In Stock |
|
| 50MG | 259 | In Stock |
|
| 100MG | 405 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDdr1-In-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionDDR1-IN-1 is an effective and specific DDR1 receptor tyrosine kinase inhibitor (IC50: 105 nM), about 3-fold selectivity over DDR2.
-
DescriptionDDR1-IN-1 is an effective and specific DDR1 receptor tyrosine kinase inhibitor (IC50: 105 nM), about 3-fold selectivity over DDR2.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetDNA/RNA Synthesis
-
RecptorDDR1| DDR2
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1449685-96-4
-
Formula Weight552.6
-
Molecular FormulaC30H31F3N4O3
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 41 mg/mL. 74.20 mM
-
SMILESCCN1CCN(CC1)Cc1c(cc(cc1)C(=O)Nc1cc(c(cc1)C)Oc1cc2c(cc1)NC(=O)C2)C(F)(F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kim HG, et al. ACS Chem Biol. 2013, 8(10), 2145-2150.
molnova catalog
related products
-
CID 5951923
CID 5951923 is an inhibitor of KLF5 transcription factor with an IC50 of 603 nM.
-
Proflavine Hemisulfa...
Proflavine Hemisulfate is a topical antiseptic by interchelating DNA, thereby disrupting DNA synthesis and leading to high levels of mutation in the copied DNA strands.
-
Cyclocytidine hydroc...
Cyclocytidine is the prodrug of cytarabine, which is a pyrimidine nucleoside analog that inhibits the DNA synthesis and used mainly in the treatment of leukemia.
